121
Views
11
CrossRef citations to date
0
Altmetric
Original Research

The impact of atrial fibrillation in patients with COPD during hospitalization

&
Pages 2105-2112 | Published online: 10 Jul 2018

References

  • KinoshitaMHergesRMHodgeDORole of smoking in the recurrence of atrial arrhythmias after cardioversionAm J Cardiol2009104567868219699344
  • KorantzopoulosPKolettisTMGalarisDGoudevenosJAThe role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillationInt J Cardiol2007115213514316764958
  • OgiHNakanoYNiidaSIs structural remodeling of fibrillated atria the consequence of tissue hypoxia?Circ J20107491815182120631454
  • SalpeterSROrmistonTMSalpeterEECardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysisChest200412562309232115189956
  • ChristiansenCFChristensenSMehnertFCummingsSRChapurlatRDSørensenHTGlucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control studyArch Intern Med2009169181677168319822824
  • LiaoKMChenCYIncidence and risk factors of atrial fibrillation in Asian COPD patientsInt J Chron Obstruct Pulmon Dis2017122523253028883719
  • MiyasakaYBarnesMEBaileyKRMortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based studyJ Am Coll Cardiol200749998699217336723
  • AsbachSOlschewskiMFaberTSZehenderMBodeCBrunnerMMortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patientsEuropace200810439139418326852
  • StewartSHartCLHoleDJMcMurrayJJA population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyAm J Med2002113535936412401529
  • KirchhofPAuricchioABaxJCrijnsHOutcome parameters for trials in atrial fibrillation: executive summaryEur Heart J200728222803281717897924
  • BenjaminEJWolfPAD’AgostinoRBSilbershatzHKannelWBLevyDImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation199898109469529737513
  • VidailletHGranadaJFChyouPOA population-based study of mortality among patients with atrial fibrillation or flutterAm J Med2002113536537012401530
  • RuigómezAJohanssonSWallanderMAGarcía RodríguezLARisk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillationBMC Cardiovasc Disord20022511897013
  • HuangBYangYZhuJClinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry studyJ Am Med Dir Assoc201415857658124894999
  • LiaoKMLinTCLiCYYangYHDementia increases severe sepsis and mortality in hospitalized patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)20159423e96726061334
  • ShenHNLuCLLiCYDementia increases the risks of acute organ dysfunction, severe sepsis and mortality in hospitalized older patients: a National Population-Based StudyPLoS One20127e4275122905169
  • Méndez-BailónMLopez-de-AndrésAde Miguel-DiezJChronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. An observational study using hospital discharge data in Spain (2004–2013)Int J Cardiol201723620921528190617
  • CanepaMStraburzynska-MigajEDrozdzJCharacteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term RegistryEur J Heart Fail201820110011028949063
  • OnishiKTotal management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular diseaseJ Cardiol201770212813428325523
  • FusoLIncalziRAPistelliRPredicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary diseaseAm J Med19959832722777872344
  • LahousseLNiemeijerMNvan den BergMEChronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam studyEur Heart J201536271754176125920404
  • García-SanzM-TCánive-GómezJCSenín-RialLOne-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary diseaseJ Thorac Dis20179363664528449471
  • KarajamakiAJPatsiOPSavolainenMKesaniemiYAHuikuriHUkkolaONon-alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population (OPERA Study)PLoS One20151011e014293726571029
  • TargherGValbusaFBonapaceSNon-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetesPLoS One201382e5718323451184
  • KäräjämäkiAJKettunenOLepojärviSPresence of atrial fibrillation is associated with liver stiffness in an elderly Finnish populationPLoS One2017123e017385528288202
  • LiangSKisselevaTBrennerDAThe role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblastsFront Physiol201671726869935
  • YounJYZhangJZhangYOxidative stress in atrial fibrillation: an emerging role of NADPH oxidaseJ Mol Cell Cardiol201362727923643589
  • HoJEYinXLevyDGalectin 3 and incident atrial fibrillation in the communityAm Heart J2014167572973424766984
  • KornejJSchmidlJUeberhamLGalectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablationPLoS One2015104e012357425875595
  • LiLCLiJGaoJFunctions of galectin-3 and its role in fibrotic diseasesJ Pharmacol Exp Ther2014351233634325194021
  • ChengCLLeeCHChenPSLiYHLinSJYangYHValidation of acute myocardial infarction cases in the National Health Insurance Research Database in TaiwanJ Epidemiol201424650050725174915